Cargando…

Human Cutaneous Leishmaniosis in Iran, Up to Date-2019

Cutaneous leishmaniasis is a neglected and parasitic vector borne diseases that is endemic in tropical and subtropical countries, including Iran. The aim of this study was to explain the present status of CL in Iran. This report is based on data that recorded by cutaneous leishmaniasis surveillance...

Descripción completa

Detalles Bibliográficos
Autores principales: Razavi, Mohamad Reza, Shirzadi, Mohammad Reza, Mohebali, Mehdi, Yaghoobi-Ershadi, Mohammad Reza, Vatandoost, Hassan, Shirzadi, Mehrshad, Gouya, Mohammad Mehdi, Gharachorloo, Faranak, Arshi, Shahnam, Amiri, Behzad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tehran University of Medical Sciences 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8782751/
https://www.ncbi.nlm.nih.gov/pubmed/35111852
http://dx.doi.org/10.18502/jad.v15i2.7483
_version_ 1784638379906826240
author Razavi, Mohamad Reza
Shirzadi, Mohammad Reza
Mohebali, Mehdi
Yaghoobi-Ershadi, Mohammad Reza
Vatandoost, Hassan
Shirzadi, Mehrshad
Gouya, Mohammad Mehdi
Gharachorloo, Faranak
Arshi, Shahnam
Amiri, Behzad
author_facet Razavi, Mohamad Reza
Shirzadi, Mohammad Reza
Mohebali, Mehdi
Yaghoobi-Ershadi, Mohammad Reza
Vatandoost, Hassan
Shirzadi, Mehrshad
Gouya, Mohammad Mehdi
Gharachorloo, Faranak
Arshi, Shahnam
Amiri, Behzad
author_sort Razavi, Mohamad Reza
collection PubMed
description Cutaneous leishmaniasis is a neglected and parasitic vector borne diseases that is endemic in tropical and subtropical countries, including Iran. The aim of this study was to explain the present status of CL in Iran. This report is based on data that recorded by cutaneous leishmaniasis surveillance system in 2019, and evaluated in Center for Communicable Diseases Management in Ministry of Health in Iran. Iran has been considered an endemic area for cutaneous leishmaniasis in the world. Dependent to activities for cutaneous leishmaniasis control the number of cases decreased from 23202 in 2008 (Incidence rate 32 per 100000) to 13124 in 2019 (Incidence rate 15.8 per 100000), more cases reported from September to December, in 2019, 46% of cases had one lesion and 21% had 2 lesions, 85% of cases diagnosed when the diameter of lesions had 3 centimeters and bellows. Although the Leishmania control program began in 1977, the incidence of the disease has dropped dramatically since 2008 when the new cutaneous leishmaniasis control program have been implemented. Although in some areas the incidence of the disease increased, but the implementation of the new program has reduced the number of cases, in order to continue reducing the disease, permanent support for the control programs is needed.
format Online
Article
Text
id pubmed-8782751
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Tehran University of Medical Sciences
record_format MEDLINE/PubMed
spelling pubmed-87827512022-02-01 Human Cutaneous Leishmaniosis in Iran, Up to Date-2019 Razavi, Mohamad Reza Shirzadi, Mohammad Reza Mohebali, Mehdi Yaghoobi-Ershadi, Mohammad Reza Vatandoost, Hassan Shirzadi, Mehrshad Gouya, Mohammad Mehdi Gharachorloo, Faranak Arshi, Shahnam Amiri, Behzad J Arthropod Borne Dis Review Article Cutaneous leishmaniasis is a neglected and parasitic vector borne diseases that is endemic in tropical and subtropical countries, including Iran. The aim of this study was to explain the present status of CL in Iran. This report is based on data that recorded by cutaneous leishmaniasis surveillance system in 2019, and evaluated in Center for Communicable Diseases Management in Ministry of Health in Iran. Iran has been considered an endemic area for cutaneous leishmaniasis in the world. Dependent to activities for cutaneous leishmaniasis control the number of cases decreased from 23202 in 2008 (Incidence rate 32 per 100000) to 13124 in 2019 (Incidence rate 15.8 per 100000), more cases reported from September to December, in 2019, 46% of cases had one lesion and 21% had 2 lesions, 85% of cases diagnosed when the diameter of lesions had 3 centimeters and bellows. Although the Leishmania control program began in 1977, the incidence of the disease has dropped dramatically since 2008 when the new cutaneous leishmaniasis control program have been implemented. Although in some areas the incidence of the disease increased, but the implementation of the new program has reduced the number of cases, in order to continue reducing the disease, permanent support for the control programs is needed. Tehran University of Medical Sciences 2021-06-30 /pmc/articles/PMC8782751/ /pubmed/35111852 http://dx.doi.org/10.18502/jad.v15i2.7483 Text en Copyright © 2021 The Authors. Published by Tehran University of Medical Sciences https://creativecommons.org/licenses/by-nc/4.0/This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International license (https://creativecommons.org/licenses/by-nc/4.0/). Non-commercial uses of the work are permitted, provided the original work is properly cited.
spellingShingle Review Article
Razavi, Mohamad Reza
Shirzadi, Mohammad Reza
Mohebali, Mehdi
Yaghoobi-Ershadi, Mohammad Reza
Vatandoost, Hassan
Shirzadi, Mehrshad
Gouya, Mohammad Mehdi
Gharachorloo, Faranak
Arshi, Shahnam
Amiri, Behzad
Human Cutaneous Leishmaniosis in Iran, Up to Date-2019
title Human Cutaneous Leishmaniosis in Iran, Up to Date-2019
title_full Human Cutaneous Leishmaniosis in Iran, Up to Date-2019
title_fullStr Human Cutaneous Leishmaniosis in Iran, Up to Date-2019
title_full_unstemmed Human Cutaneous Leishmaniosis in Iran, Up to Date-2019
title_short Human Cutaneous Leishmaniosis in Iran, Up to Date-2019
title_sort human cutaneous leishmaniosis in iran, up to date-2019
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8782751/
https://www.ncbi.nlm.nih.gov/pubmed/35111852
http://dx.doi.org/10.18502/jad.v15i2.7483
work_keys_str_mv AT razavimohamadreza humancutaneousleishmaniosisiniranuptodate2019
AT shirzadimohammadreza humancutaneousleishmaniosisiniranuptodate2019
AT mohebalimehdi humancutaneousleishmaniosisiniranuptodate2019
AT yaghoobiershadimohammadreza humancutaneousleishmaniosisiniranuptodate2019
AT vatandoosthassan humancutaneousleishmaniosisiniranuptodate2019
AT shirzadimehrshad humancutaneousleishmaniosisiniranuptodate2019
AT gouyamohammadmehdi humancutaneousleishmaniosisiniranuptodate2019
AT gharachorloofaranak humancutaneousleishmaniosisiniranuptodate2019
AT arshishahnam humancutaneousleishmaniosisiniranuptodate2019
AT amiribehzad humancutaneousleishmaniosisiniranuptodate2019